Brief: Cell Impact To Issue About 16.8 Mln B Shares

Cell Impact AB (publ)

30/11/2021 09:54

Nov 30 (Reuters) - CELL IMPACT AB (PUBL)  CIb.ST :
    * SAID ON MONDAY ISSUE OF UP TO 16,812,094 SERIES B SHARES
WITH
PREFERENTIAL RIGHT FOR THE COMPANY'S EXISTING SHAREHOLDERS
    * PURPOSE OF ISSUE IS CONTINUED FINANCING OF CELL IMPACT'S
BUSINESS PLAN, WHICH INCLUDES INCREASING THE COMPANY'S
PRODUCTION CAPACITY
    * THE SUBSCRIPTION PERIOD IN THE RIGHTS ISSUE IS SET TO TAKE
PLACE
DECEMBER 9-23, 2021
    * THE SUBSCRIPTION PRICE IN THE RIGHTS ISSUE IS SEK 20.75
PER
SERIES B SHARE
    * HAS OBTAINED A BRIDGE LOAN FACILITY WITH A FRAMEWORK OF UP
TO
SEK 50 MILLION PROVIDED BY CARNEGIE INVESTMENT BANK AB IN
CONNECTION WITH THE RIGHTS ISSUE. ANY DRAWN AMOUNT WILL BE
REPAID AND THE FACILITY WILL CEASE TO EXIST AFTER THE COMPLETION
OF THE RIGHTS ISSUE

   
 Source text for Eikon:  urn:newsml:reuters.com:*:nBQN7CN0hY
 Further company coverage:  CIb.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))